Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery
Recruiting · NCT02166372 · Observational (researchers observe without assigning treatment) · Lead sponsor: Min-Sheng General Hospital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
T2DM has become a major health burden for our society. More and more data support the relative effectiveness of gastrointestinal metabolic surgery, known as bariatric surgery, in the remission of T2DM of BMI less35. The metabolic surgery guidelines of IDF recommend BMI over 27.5 in Asia. The evidence reviewed above strongly points to the need for a large randomized, controlled trial to evaluate the risks and benefits of obesity surgery in the treatment of type 2 diabetes Mellitus. This study is expected to provide very significant findings about the natural course of diabetes in obese diabetic patients.
Who can take part
Inclusion criteria
- Diabetic Mellitus Type 2 medically controlled at Diabetes Center for at least six months
- BMI over 25
- age between 20 and 67
Exclusion criteria
- Diagnosed with cancer within past five years
- HIV positive
- Active TB patients
- CV events in past six months
- serum cretinine over 2.0 mg/dl
- C-peptide bellow 1.0 ng/ml in past three months
- Diabetic retinopathy; vision bellow 0.1
- Cushing's syndrome
- History of organ transplant
- History of bariatric surgery
- History of alcohol or drug dependency in past five years
- Psychological problems likely to interfere with adherence to protocol
Where it is running
1 location listed.
- Min-Sheng General Hospital - Taoyuan City, Taiwan